€1.94
3.19% yesterday
Xetra, Jun 30, 05:36 pm CET
ISIN
DE0005203947
Symbol
BNN
Index
Sector
Industry

BRAIN Biotech Stock price

€1.94
-0.16 7.62% 1M
-1.61 45.35% 6M
-1.61 45.35% YTD
-0.38 16.38% 1Y
-6.06 75.75% 3Y
-6.48 76.96% 5Y
-7.16 78.68% 10Y
-7.16 78.68% 20Y
Xetra, Closing price Mon, Jun 30 2025
+0.06 3.19%
ISIN
DE0005203947
Symbol
BNN
Index
Sector
Industry

Key metrics

Basic
Market capitalization
€41.1m
Enterprise Value
€30.6m
Net debt
positive
Cash
€15.1m
Shares outstanding
21.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.77 | 0.66
EV/Sales
0.57 | 0.49
EV/FCF
negative
P/B
7.05
Financial Health
Equity Ratio
14.22%
Return on Equity
-88.19%
ROCE
-16.78%
ROIC
-21.94%
Debt/Equity
0.76
Financials (TTM | estimate)
Revenue
€53.5m | €61.9m
EBITDA
€-5.2m | €3.5m
EBIT
€-10.1m
Net Income
€-13.7m | €-1.8m
Free Cash Flow
€-7.6m
Growth (TTM | estimate)
Revenue
-4.89% | 11.46%
EBITDA
-4,600.00% | 188.47%
EBIT
-106.52%
Net Income
-69.69% | 83.47%
Free Cash Flow
-46.07%
Margin (TTM | estimate)
Gross
55.60%
EBITDA
-9.65% | 5.61%
EBIT
-18.87%
Net
-25.52% | -2.97%
Free Cash Flow
-14.22%
More
EPS
€-0.63
FCF per Share
€-0.35
Short interest
-
Employees
296.00
Rev per Employee
€190.00k
Show more

Is BRAIN Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

BRAIN Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a BRAIN Biotech forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a BRAIN Biotech forecast:

Buy
78%
Hold
22%

Financial data from BRAIN Biotech

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
54 54
5% 5%
100%
- Direct Costs 24 24
1% 1%
44%
30 30
8% 8%
56%
- Selling and Administrative Expenses 24 24
8% 8%
46%
- Research and Development Expense - -
-
-
-5.17 -5.17
4,600% 4,600%
-10%
- Depreciation and Amortization 4.93 4.93
3% 3%
9%
EBIT (Operating Income) EBIT -10 -10
107% 107%
-19%
Net Profit -14 -14
70% 70%
-26%

In millions EUR.

Don't miss a Thing! We will send you all news about BRAIN Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

B.R.A.I.N. Biotechnology Research & Information Network AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Ulrich Putsch, Holger Zinke, Gabriele Sachse, and Hans-Günter Gassen in 1993 and is headquartered in Zwingenberg, Germany.

Head office Germany
CEO Erik Vries
Employees 296
Founded 1993
Website www.brain-biotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today